Freestone Grove Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.7M Buy
195,214
+191,217
+4,784% +$12.5M 0.1% 254
2025
Q1
$268K Sell
3,997
-682
-15% -$45.7K ﹤0.01% 494
2024
Q4
$259K Buy
+4,679
New +$259K ﹤0.01% 492